News & Events2020-01-20T09:52:20+01:00

News & Events

To subscribe to our newsletter, please send an email to newsletter@redbiotec.ch.

1502, 2021

Expansion of platform – adding bifidobacteria and yeast

February 15th, 2021|

Redbiotec has expanded its platform by adding further microorganisms. In order to express proteins and small molecules at high yield, among other for the manufacturing of products in the food industry, Redbiotec has implemented yeast and bifidobacteria.

2905, 2020

BIO Digital 2020

May 29th, 2020|

Date: June 8-12, 2020

At a time when collaboration is more vital than ever, the Redbiotec team looks forward to connecting with industry partners at BIO Digital 2020.

1803, 2020

Redbiotec Signs Collaboration Agreement with Large-Cap Pharma to Develop Targeted Living Medicines

March 18th, 2020|

Redbiotec AG has entered into a research collaboration and exclusive option agreement with a large-cap pharmaceutical company. The collaboration will leverage Redbiotec’s proprietary bacteria platform BRISPR® for the targeted delivery of gene therapy cargos from the partner.

“Redbiotec’s bacteria hold great potential in overcoming the delivery hurdles faced by conventional vehicles, such as adeno-associated viruses (AAVs) and nanoparticles. It is our goal to empower promising gene therapies for unmet medical needs through safe and targeted delivery,” said Christian Schaub, CEO of Redbiotec. “We are very pleased with our first pharma partnership on the BRISPR® platform. Together, we will push the boundaries and create a new class of genetic medicines.” 

1812, 2019

Outlook 2020

December 18th, 2019|

We thank you for your trust and support in 2019 and we wish you all the best in the forthcoming year! Best wishes, Christian Schaub, CEO, on behalf of the Redbiotec Team.

2020 marks an exciting year ahead for Redbiotec as the team gears up for more milestones. New partnerships and investment in growth will be essential pillars towards achieving our vision.

Go to Top